MetLife Inc 5.625% Series E Preferred Stock
MET.PRE
5 hedge funds and large institutions have $8.09M invested in MetLife Inc 5.625% Series E Preferred Stock in 2024 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 0 reducing their positions, and closing their positions.
25% more funds holding
Funds holding: 4 → 5 (+1)
0.01% more ownership
Funds ownership: 1.06% → 1.07% (+0.01%)
4% less capital invested
Capital invested by funds: $8.44M → $8.09M (-$349K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CGH
Crossmark Global Holdings
Houston,
Texas
|
+$57.5K |
| 2 |
PNC Financial Services Group
Pittsburgh,
Pennsylvania
|
+$1.51K |
Top Sellers
MET.PRE Hedge Fund Activity: Q4 2024 in Review
5 of the 7,593 institutional investors tracked by Wall St. Rank reported a position in MetLife Inc 5.625% Series E Preferred Stock (MET.PRE) for Q4 2024, worth a combined $8.09M — down 4.1% from $8.44M a quarter earlier.
Buyers outnumbered sellers: 1 fund opened new MET.PRE positions and 0 closed out — a net gain of 1 holder — while 2 added to existing stakes and 0 trimmed.
The largest buyer was Crossmark Global Holdings, adding an estimated $57.5K.
- 5 institutional investors held MetLife Inc 5.625% Series E Preferred Stock (MET.PRE) as of Q4 2024, up from 4 in Q3 2024.
- Funds reported $8.09M of MetLife Inc 5.625% Series E Preferred Stock stock for Q4 2024, down 4.1% quarter-over-quarter.
- 1 fund opened new MetLife Inc 5.625% Series E Preferred Stock positions in Q4 2024 and 0 closed out, a net change of +1 holder.
- The largest MetLife Inc 5.625% Series E Preferred Stock buyer in Q4 2024 was Crossmark Global Holdings, an estimated $57.5K added.
Based on aggregated 13F filings for Q4 2024.